Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 398.01K | 232.00K | 5.07M | 1.59M | 134.60K |
Gross Profit | -134.91K | 91.44K | 4.59M | 1.30M | -195.72K |
EBITDA | -23.67M | -27.99M | -21.41M | -19.79M | -11.36M |
Net Income | -24.43M | -28.88M | -22.09M | -20.98M | -29.88M |
Balance Sheet | |||||
Total Assets | 23.05M | 20.18M | 29.18M | 23.78M | 22.65M |
Cash, Cash Equivalents and Short-Term Investments | 20.00M | 14.34M | 23.12M | 19.37M | 19.02M |
Total Debt | 1.17M | 1.70M | 2.95M | 1.80M | 3.74M |
Total Liabilities | 3.22M | 3.35M | 5.46M | 4.84M | 5.93M |
Stockholders Equity | 19.83M | 16.83M | 23.72M | 18.94M | 16.72M |
Cash Flow | |||||
Free Cash Flow | -15.96M | -17.66M | -19.88M | ― | ― |
Operating Cash Flow | -15.88M | -17.53M | -19.69M | -13.69M | -11.17M |
Investing Cash Flow | -72.65K | -132.60K | -183.52K | ― | ― |
Financing Cash Flow | 22.60M | 8.84M | 25.38M | 14.19M | 23.92M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | ¥238.13B | 15.93 | 6.62% | 2.46% | 9.00% | -0.33% | |
66 Neutral | AU$103.73M | 11.33 | 12.90% | 4.19% | 23.66% | -7.71% | |
41 Neutral | $410.83M | ― | -133.28% | ― | 72.47% | 20.08% | |
― | $34.95M | ― | -92.68% | ― | ― | ― | |
68 Neutral | AU$710.75M | 109.15 | 11.59% | ― | 9.76% | -28.92% | |
39 Underperform | AU$471.12M | ― | -46.55% | ― | 905.48% | 10.02% | |
23 Underperform | AU$181.10M | ― | ― | -100.00% | 44.26% |
BrainChip Holdings Ltd reported a strong financial position for the June 2025 quarter, with a cash balance of US$13.5 million, indicating robust potential for growth and investment in research and development. The company decided to remain listed on the ASX after evaluating a potential redomicile, emphasizing its commitment to shareholder value. Notable collaborations were formed with companies like Arquimea, Andes Technology, and Chelpis Quantum Corp, showcasing the commercial viability and application of BrainChip’s Akida technology in diverse sectors such as water safety, AI computation, and industrial robotics. These partnerships highlight BrainChip’s strategic positioning in the AI industry and its ongoing expansion of its intellectual property portfolio, which now includes 55 patents.
BrainChip Holdings Ltd announced the issuance of 580,000 options and 1,000,000 restricted stock units as part of an employee incentive scheme, which are not intended to be quoted on the ASX. This move is likely aimed at enhancing employee retention and motivation, potentially strengthening the company’s operational capabilities and market position in the competitive AI and technology sector.
BrainChip Holdings Ltd announced the issuance of 2,236,485 ordinary fully paid securities as part of their latest financial activities. This move reflects the company’s ongoing efforts to manage its equity and potentially strengthen its financial position, which could have implications for its market strategy and stakeholder interests.
BrainChip Holdings Ltd has announced the issuance of 4,688,000 restricted stock units as part of an employee incentive scheme. This move is expected to enhance employee engagement and align their interests with the company’s long-term growth objectives, potentially strengthening BrainChip’s position in the competitive AI technology market.
BrainChip Holdings Ltd announced a change in the director’s interest, specifically regarding Pia Turcinov, who disposed of 175,331 ordinary shares to meet Australian tax liabilities related to the historical vesting of performance rights. This transaction reflects the company’s adherence to regulatory requirements and transparency in director dealings, potentially impacting investor perceptions and stakeholder confidence.
BrainChip Holdings Ltd announced a change in the director’s interest, with Director Antonio Jose Florindo Viana disposing of 130,000 ordinary shares valued at $27,950. This transaction was conducted to facilitate the payment of US Federal and State Taxes related to the vesting of Restricted Stock Units. The change reflects the director’s financial management strategy and does not indicate a shift in the company’s operational or strategic direction.
BrainChip Holdings Ltd announced a change in the director’s interest notice, with Director Duy-Loan Thi Le acquiring 697,674 Ordinary Shares as a result of the vesting of Restricted Stock Units. This change reflects an increase in her direct and indirect holdings in the company, with no cash consideration involved. The announcement highlights the company’s ongoing commitment to aligning its leadership’s interests with shareholder value, potentially impacting its market perception and stakeholder confidence.
BrainChip Holdings Ltd has announced a change in the director’s interest, specifically regarding Pia Turcinov’s holdings. On May 23, 2025, Ms. Turcinov acquired 766,799 Ordinary Shares through the vesting of Performance Rights, while disposing of 69,125 Performance Rights. This change reflects a strategic adjustment in the director’s shareholding, potentially impacting the company’s stakeholder dynamics and market perception.
BrainChip Holdings Ltd has announced a change in the interests of its director, Antonio Jose Florindo Viana, in the company’s securities. The change involves the conversion of 697,674 Restricted Stock Units into the same number of Ordinary Shares, resulting in Mr. Viana holding a total of 3,130,018 Fully Paid Ordinary Shares. This adjustment reflects the vesting of Restricted Stock Units under the company’s Employee Share Plan Trust, with no cash consideration involved. The shares were valued at $0.22 per share as of May 22, 2025. This change in director’s interest is part of the company’s ongoing governance and compliance with ASX regulations.
BrainChip Holdings Ltd announced the cancellation of a previous notification regarding the issue, conversion, or payment of unquoted equity securities. This decision was made because service rights have vested but do not automatically convert to shares unless the holder chooses to exercise them, impacting the company’s equity management strategy.
BrainChip Holdings Ltd has announced the issuance of 2,093,022 fully paid ordinary securities as of May 23, 2025. This move indicates the company’s strategic financial maneuvers to potentially enhance its market position and operational capabilities, reflecting a proactive approach to leveraging its equity for growth and development. The issuance of these securities may have implications for stakeholders, suggesting an expansion or strengthening of the company’s financial foundation.
BrainChip Holdings Ltd has announced the issuance of 1,395,348 ordinary fully paid securities as of May 23, 2025. This move involves the conversion of unquoted options or other convertible securities, which could potentially impact the company’s financial structure and market positioning by increasing its capital base.